https://www.tech-generation.fr/2023/06/16/lockbit-a-t-il-frappe-le-geant-pharmaceutique-granules-india/
LockBit a-t-il frappé le géant pharmaceutique Granules India ? - Tech Generation
Jun 16, 2023 - Le groupe de ransomware lié à la Russie, LockBit, a-t-il revendiqué la responsabilité d’une cyberattaque contre le géant pharmaceutique indien Granules India ?...
a tgranules indialockbitpharmaceutiquetech
https://fyers.in/stocks/granules-india-ltd?tabs=shareholding
Granules India Share Price Today - Live GRANULES NSE/BSE Stock Price
Granules India stock price today, live on NSE/BSE with FYERS. View GRANULES current share price, market cap, 52-week high/low, share value and price target...
granules indiashare pricetodaylivense
https://fluval.co.in/product/bug-bites-goldfish-granules-s-m-45-g-1-6-oz/
Bug Bites Goldfish Granules (S-M), 45 g (1.6 oz) - Fluval India
Dec 12, 2025 - Buy Now and enhance the health and vibrancy of your goldfish with Fluval Bug Bites Goldfish Granules. Packed with premium ingredients for optimal nutrition.
bug bitesgoldfishgranulesfluvalindia
https://hindi.economictimes.com/markets/share-bazaar/granules-india-share-jump-20-percent-in-3-month-now-this-stock-show-break-out-from-rounding-bottom-pattern-know-expert-view/articleshow/108036424.cms
Granules India शेयर 3 महीने में 20% बढ़ा! राउंडिंग बॉटम पैटर्न से दिखा ब्रेकआउट, क्या दांव लगाना...
Granules India Share Price: फार्मा सेक्टर स्टॉक ग्रेन्यूल्स इंडिया लिमिटेड पर मार्केट के एक्सपर्ट का मानना है कि अगले 3 महीने में 590 रुपए के टारगेट प्राइस को...
granules india
https://health.economictimes.indiatimes.com/news/pharma/drug-approvals-launches/granules-india-receives-usfda-approval-for-otc-equivalent-of-advil-dual-action-tablets/101753655
Granules India receives USFDA approval for OTC equivalent of Advil Dual Action tablets,...
Granules India: The approved drug is called Acetaminophen and Ibuprofen tablets, with a strength of 250 mg/125 mg, and it can be purchased over the counter...
advil dual actiongranules indiareceivesusfdaapproval
https://pharma.economictimes.indiatimes.com/news/pharma-industry/granules-india-q2-profit-falls-on-weak-demand-in-north-america-europe/115014738
Granules India Q2 profit falls on weak demand in North America, Europe, ETPharma
The company said its quarterly sales were impacted by a voluntary pause in manufacturing and distribution from its Gagillapur facility near Hyderabad, which...
granules indiafalls onnorth americaprofitweak